Slideshow
Author(s):
How common is psychosis in PD? Implications? Risk factors? Insights here, and measures that may help.
European Commission Grants NLX-112 Orphan Medicinal Product Designation for Spinocerebellar Ataxia
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
NeurologyLive® Friday 5 — October 4, 2024
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
NORAPS Phase 2 Trial to Test Noradrenaline Reuptake Inhibitor Atomoxetine in PSP Apathy and Impulsivity
Continued Progress in Phase 1 Study of Antisense Oligonucleotide ION464 in MSA